Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00100997
Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00100997
Protocol Section: NCT00100997
Start Identification Module Data
Expand Identification Module Data
Brief Title: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
Official Title: A Phase 1 Multicenter Open-Label Dose-Escalation Safety Pharmacokinetic and Pharmacodynamic Study of Intravenously Administered CNF1010 17-Allylamino-17-Demethoxygeldanamycin 17-AAG in Patients With Gleevec-Resistent Chronic Myelogenous Leukemia
Acronym: None
Organization: National Cancer Institute NCI
Organization Class: NIH
Organization Study ID: UCLA-0408048-01
Secondary IDs
Secondary ID Type Domain Link
CDR0000407499 REGISTRY None None
CTC-CNF1010 None None None
CTC-CNF1010-CML-04001 Registry Identifier PDQ Physician Data Query None
Start Status Module Data
Status Verified Date: 2005-05
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Jonsson Comprehensive Cancer Center
Lead Sponsor Class: OTHER
Lead Sponsor: Jonsson Comprehensive Cancer Center
Start Oversight Module Data No Oversight Module Defined
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload